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Carotid endarterectomy (CEA) has been shown
to reduce the risk of stroke in selected symptomatic
and asymptomatic patients with high-grade internal
carotid artery stenosis.1-3 However, this advantage
depends on low perioperative morbidity (notably,
stroke) and mortality rates, and it has been suggest-
ed that rates in excess of 3% to 5% would negate the
surgical benefit.4 Specifically, identification of
groups at higher risk for perioperative complications
could potentially question the propriety of the oper-
ation in those groups. 
Multiple retrospective reports, analyses of
prospective trials, and meta-analyses have identified
female gender as a risk factor for perioperative stroke
and death after CEA, with subsequent implications
as to the benefit of CEA in women.5-10 This dispar-
ity among benefit, perioperative risk, and gender has
led to both a nonuniform support of CEA, particu-
larly in asymptomatic female patients, and a demand
for additional information about CEA in women.9,11
An increasing number of patients, male and
female, are undergoing CEA, with an enormous
impact on public health dollars; even small differ-
ences in perioperative outcome may tip the balance
against CEA.12,13 Therefore, in an effort to define
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tor for perioperative stroke and death after carotid endarterectomy (CEA). 
Methods: Data for all patients who underwent CEA at a single institution from January
1990 to December 1998 were entered into a computerized vascular registry and form
the basis of this report. 
Results: A total of 1298 CEA procedures were performed, of which 520 (40%) were in
women and 778 (60%) in men. The mean age was 69.8 ± 8.7 years for men and 71.2 ±
8.5 years for women (P < .001). Cardiac risk factors significantly varied among the two
groups, with women more likely to have diabetes (42% vs 36%) and hypertension (77%
vs 66%), whereas tobacco history was higher among men (85% vs 71%) (P < .05 for all).
Female patients were more likely to be asymptomatic at presentation (men, 44% vs
women, 51%; P = .022). Postoperative myocardial infarction occurred in eight patients
(0.6%) with no differences between men (0.4%) and women (1.0%) (P = not significant).
For all adverse postoperative cardiac events (myocardial infarction, congestive heart fail-
ure, or arrhythmia), the incidence was 1.9% (25 patients), again with no differences
between men (1.5%) and women (2.5%) (P = not significant). There were 25 postoper-
ative neurologic events (19 strokes, six transient ischemic attacks) among the entire
cohort (1.9%), of which 16 were in men (2.1%) and nine in women (1.6%; P = not sig-
nificant). The overall postoperative stroke rate was 1.5% (13 [1.7%] of 778 men; 6
[1.2%;] of 520 women; P = not significant). Total operative mortality was 0.3% (3
[0.4%] of 778 men; 1 [0.2%] of 778 women; P = not significant). Late recurrent steno-
sis requiring operation developed in 14 patients (1.1%) during follow-up (6 [0.8%] of
778 men; 8 [1.5%] of 520 women; P = .19).
Conclusions: Although there is significant variability in cardiac risk factors and presenta-
tion, female gender is not a risk factor for stroke, death, or cardiac morbidity after CEA.
Women are not at higher risk for reoperation for recurrent stenosis. (J Vasc Surg
2000;31:1103-9.)
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sex differences in perioperative risk and outcome, we
present our experience with CEA in a large popula-
tion of patients.
PATIENTS AND METHODS
Since January 1990, data from every patient who
has undergone vascular surgery at our institution
have been entered into a computerized vascular reg-
istry. We reviewed the data on all consecutive
patients who underwent CEA between January
1990 and December 1998. Patients who underwent
simultaneous cardiac or aortic arch procedures were
excluded from this report.
A total of 1298 CEA procedures were performed
on 1155 patients, of which 520 (40%) were in
women and 778 (60%) in men. Bilateral CEAs were
analyzed according to the individual side; therefore,
1298 procedures were analyzed. Clinical presenta-
tion was classified as asymptomatic, transient
ischemic attack (TIA) (temporary focal neurologic
deficit lasting < 24 hours, with complete recovery),
or stroke (cerebrovascular accident). Patients who
had nonhemispheric symptoms, such as dizzy spells
or vertigo, were classified as asymptomatic.
Internal carotid artery percent stenosis was
derived from arteriography, duplex ultrasound scan,
or magnetic resonance angiogram. Arteriography
was performed with lower frequency during the later
periods of the study, consistent with other reports.14
Most procedures were performed under general
anesthesia (Table I) with no difference between the
type of anesthetic among the male and female
patients. Anesthetic type was based on individual
surgeon preference. Intraoperative electroen-
cephalogram monitoring was not used. Shunting
was performed routinely in all patients who under-
went general anesthesia. Patch angioplasty was used
selectively on a subjective examination of internal
carotid artery size (without actual caliper measure-
ment of internal carotid artery diameter) and was
used routinely in all patients who had recurrent
stenoses. As seen in Table II, women were more
likely to have patch closure of the carotid artery.
Outcomes are reported as in-hospital events.
Postoperative neurologic morbidity was classified as
either a TIA (lasting < 24 hours, full recovery) or a
permanent stroke (deficit present at time of hospital
discharge). A computed tomographic scan of the
head was performed in all patients who had a new
neurologic deficit after surgery. A postoperative elec-
trocardiogram was obtained selectively in all patients
with a history of diabetes, coronary artery disease,
heart failure, or arrhythmia. Cardiac isoenzymes
were obtained in all patients who had new findings
on the postoperative electrocardiogram. Adverse
postoperative cardiac events were defined as postop-
erative myocardial infarction (MI) (creatine kinase
myocardial fraction ≥ 5%), congestive heart failure
(CHF), or new arrhythmia (other than sinus).
All patients were seen in the office within a
month after surgery. Follow-up consisted of a
duplex scan (using an ATL Ultramark scanner;
Advanced Technology Laboratories, Bothell, Wash)
and an office visit every 6 months. Reoperation for
recurrent stenosis was performed for all sympto-
matic restenoses and for asymptomatic recurrent
stenoses greater than 80% (peak systolic velocity >
250 cm/s and end diastolic velocity > 100 cm/s).
JOURNAL OF VASCULAR SURGERY
1104 Akbari et al June 2000
Table I. Type of anesthesia
Female patients Male patients
(n = 520) (n = 778)
General 423 (81%) 616 (79%)
Regional 87 (17%) 140 (18%)
Local 10 (2%) 22 (3%)
Table II. Patch angioplasty: incidence and type
Female Male 
patients patients
(n = 520) (n = 778) P value
No patch 216 (41%) 390 (50%) —
Patch 304 (59%) 388 (50%) .002*
Synthetic 295 (57%) 383 (49%) —
Vein 9 (2%) 5 (1%) —
*P = .002 for patch versus no patch.
Table III. Clinical characteristics
Female patients Male patients
(n = 520) (n = 778) P value
Age (y, mean ± SD) 71.2 ± 8.5 69.8 ± 8.7 < .001
Smoking
Current 92 (18%) 132 (17%) —
Former 273 (53%) 530 (68%) —
Never 111 (21%) 71 (9%) < .001*
Unknown 44 (8%) 45 (6%) —
Diabetes 220 (42%) 278 (36%) .02
Hypertension 400 (77%) 514 (66%) < .001
CAD 210 (40%) 386 (50%) .001
CHF 59 (11%) 66 (8%) .09
Arrhythmia 47 (9%) 91 (12%) .13
*P < .001 for current/former versus never.
CAD, Coronary artery disease; CHF, congestive heart failure.
Statistical analysis was performed with the
StatView (Abacus Systems, Berkeley, Calif) and
Minitab (State College, Pa) computer programs.
Categorical variables were compared with the χ2
test, and continuous variables were compared with
the Student t test. The Fisher exact test was per-
formed for small expected frequencies. All tests are
2-tailed, with a P value less than .05 considered sig-
nificant.
RESULTS
Patients. Demographic data are given in Table
III. Cardiac risk factors varied between the two
groups, with diabetes and hypertension being more
common among the female patients. Female
patients undergoing CEA were also older than their
male counterparts. Coexisting coronary disease and
a history of tobacco use were more common among
the male patients.
Indications for operation. The clinical presen-
tation of the two groups is given in Table IV. Among
the entire cohort, 606 patients (47%) were asympto-
matic. Asymptomatic presentation was more com-
mon among the female patients, whereas a history of
stroke was more common among male patients
undergoing CEA.
Restenosis was an indication for operation in 57
patients (4.4%) and was more likely to be an indica-
tion among the female group (33 [6%] of 520
women) than the male group (24 [3%] of 778 men)
(P = .005). In addition, symptomatic restenosis was
more commonly an indication among the female
group (13 [2%] of 520 women vs 7 [1%] of 778
men) (P = .02).
Perioperative cardiac morbidity. Among the
entire cohort, postoperative MI occurred in eight
patients (0.6%), CHF in 10 patients (0.8%), and new
arrhythmia in seven patients (0.5%) (Table V). The
incidence of any adverse postoperative cardiac event
was 1.9% (25/1298). There was no difference
between male and female patients in the incidence of
any of these events.
Perioperative neurologic morbidity and mor-
tality. There were 25 postoperative neurologic
events (19 strokes, six TIAs) among the entire pop-
ulation (1.9%), of which 16 were in men (2.1%) and
nine in women (1.6%; P = .71) (Table VI). All
strokes were ipsilateral to the side of CEA. The over-
all postoperative stroke rate was 1.5% (19/1278)
with no difference between men and women.
Among asymptomatic patients, postoperative stroke
occurred in six patients (three men, three women)
for a postoperative stroke rate of 0.5% among all
asymptomatic patients, 0.6% for asymptomatic
female patients, and 0.4% for asymptomatic male
patients. There were no postoperative strokes
among the 57 patients who underwent repeat CEA.
In addition, as seen in Table VII, perioperative neu-
rologic morbidity was not associated with the type of
arteriotomy closure among male or female patients. 
There were four perioperative deaths during the
entire period (0.3%). Causes of death were MI in
two patients (one female), rupture of the arterioto-
my closure suture line, and stroke.
Recurrent stenosis requiring reoperation.
Follow-up was available for 910 patients (555 men
and 355 women), and 388 patients (30%) were lost
to follow-up. Mean follow-up was 24.7 months
(range, 2-104 months) with a median follow-up of
17.4 months. Of the 910 patients for whom follow-
up was available, 123 (13.5%) died during the fol-
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Table IV. Clinical presentation
Female Male
patients patients
(n = 520) (n = 778) P value
Asymptomatic 263 (51%) 343 (44%) .02
Stroke 30 (6%) 72 (9%) .02
TIA 227 (43%) 363 (47%) .29
Table V. Perioperative cardiac morbidity
Female Male
patients patients 
(n = 520) (n = 778) P value
MI 5 (1%) 3 (0.4%) .19
CHF 5 (1%) 5 (0.6%) .52
Arrhythmia 3 (0.6%) 4 (0.5%) .88
Any adverse 13 (2.5%) 12 (1.5%) .22
postoperative cardiac 
event (MI, CHF, 
arrhythmia)




(n = 520) (n = 778) P value 
Stroke 6 (1.2%) 13 (1.7%) .45
TIA 3 (0.6%) 3 (0.4%) .62
Death 1 (0.2%) 3 (0.4%) .54
low-up period (75 [13.5%] of 555 men; 48 [13.5%]
of 355 women; P = not significant). Recurrent steno-
sis requiring operation developed in 14 patients
(1.4%). Of these, six patients were men (6 [1.1%] of
555), and eight were women (8 [2.2%] of 355) (P =
.16). Ten of the 14 patients were either current or
former smokers. Symptomatic restenosis developed
in seven patients (0.5%) and manifested as a TIA in
all seven patients. In all 14 cases, the reoperation
consisted of repeat endarterectomy with patch 
closure.
DISCUSSION
The beneficial effect of CEA in the reduction of
stroke is due to a delicate balance between surgeon
and patient, in that the surgical team’s perioperative
complication rate must be weighed against the
patient’s coexisting medical conditions, clinical pre-
sentation, and life expectancy. Marginally higher
complication rates mitigate benefit: in an asympto-
matic patient, an increase of two percentage points
in complications would reduce the benefit by more
than 30%.13 Alternatively, specific patient groups at
higher risk for perioperative complications will not
receive the same benefit. For example, the
Asymptomatic Carotid Atherosclerosis Study
(ACAS) demonstrated a significant 5-year reduction
in stroke risk in men after CEA, but not in women
(66% vs 17%, 5-year reduction), possibly because of
a higher rate of preoperative stroke/death in the lat-
ter group (1.7% vs 3.6%).2 This finding, along with
other reports that have noted higher perioperative
stroke risk in women, has led to a reevaluation of the
role of CEA in women.5-10
In this study, we have shown that CEA may be
safely performed in women, and female gender is
not a risk factor for perioperative stroke, death, or
cardiac morbidity after CEA. Specifically, within a
large population of female and male patients, post-
operative neurologic morbidity and combined
stroke-death rates were virtually identical between
the two groups. 
Other patient-related variables have been corre-
lated with postoperative stroke and death. These
include recurrent stenosis, symptomatic clinical pre-
sentation, advanced age, renal insufficiency, and
hypertension.6-8,10,15,16 Although a greater percent-
age of female patients were asymptomatic at presen-
tation in this study and presumably were at lower
risk for perioperative neurologic morbidity, more
women underwent operation for symptomatic
restenosis. Therefore, perioperative risk as a function
of indication for operation was probably comparable
between the two groups. Additionally, despite a
higher age and incidence of hypertension, women
did not have any higher risk of perioperative stroke,
TIA, or death. 
Patch closure of the carotid artery was more
common among women. Because the data in this
study were retrospectively reviewed and because the
decision to use a patch was subjectively based (with-
out objective measurement of the internal carotid
artery diameter), we can only speculate as to the 
reasons behind this and the implications for the
comparable stroke rates. Anecdotal evidence has
suggested smaller artery diameter in women,17 par-
ticularly in smokers, which in turn would support
the more frequent use of patch angioplasty among
the female group in this study. In addition, lower
perioperative stroke rates have been reported with
patch closure as compared with primary closure.18
Certainly, primary closure of a small carotid artery
(which may be more frequently encountered among
women) is more prone to technical error and post-
operative neurologic morbidity. However, in the
present study we could not find an association
between the type of arteriotomy closure and periop-
erative neurologic morbidity in either female or male
patients, and perioperative stroke rates were compa-
rable in both men and women who underwent
either patch or primary closure of the carotid artery.
The incidence of cardiac morbidity was also sim-
ilar between men and women. As noted, cardiac risk
factors varied between the two groups, with diabetes
and hypertension more common among women and
smoking history and coronary artery disease more
common in men. Paciaroni et al19 recently reported
on the incidence of medical complications among
1415 patients undergoing CEA as part of the North
American Symptomatic Carotid Endarterectomy
Trial. In their study, the incidence of perioperative
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Table VII. Postoperative neurologic morbidity and
type of arteriotomy closure
Patch Primary
Females closure closure
(n = 520) (n = 304) (n = 216) P value
Stroke 4 (1.3%) 2 (0.9%) .68
TIA 2 (0.7%) 1 (0.5%) .77
Patch Primary
Males closure closure
(n = 778) (n = 388) (n = 390) P value
Stroke 6 (1.5%) 7 (1.8%) .79
TIA 1 (0.3%) 2 (0.5%) .57
MI was 1%, new arrhythmia was 1.5%, and CHF was
1%, and, similar to our findings, they did not find
any association between gender and these adverse
cardiac outcomes. However, in our study, cardiac
isoenzymes were not routinely obtained, and there-
fore, asymptomatic subendocardial MIs may have
occurred but may not have been recorded.
Although other studies have also shown no dif-
ference in perioperative stroke between men and
women, criticism may be pointed to the size and
power of those studies, raising the possibility of a
type II error. For example, Schneider et al20
described the results of CEA in 155 women and 271
men and noted a trend toward a higher postopera-
tive stroke rate among women (3.2% vs 1.5%, P =
.30). The present study provides data on almost
1300 procedures, thereby diminishing the possibili-
ty of a statistical type II error.
There appeared to be a trend toward a higher
incidence of recurrent stenosis requiring reoperation
among women in our series; however, this was not
significant. Although several studies have indicated a
higher propensity toward restenosis among women
undergoing CEA,21-23 more recent studies have not
corroborated this.24 In this study, we have only
included those patients requiring reoperation for
restenosis, which may explain the relatively low rate
of restenosis (1.0%) reported here. This compares
favorably with other series, which have reported a
1.0% to 1.7% rate of reoperation for recurrent steno-
sis.24,25 However, conclusions regarding rates of
recurrent stenosis should be made cautiously.
Because the data were examined retrospectively,
accurate end points were not well defined with each
postoperative visit, and therefore, information
regarding recurrent stenosis can only be interpreted
in the context of a repeat operation, as registered in
the database. In addition, the results of the follow-
up ultrasound scans were not entered into the data-
base. This explains why we were unable to deter-
mine the rates of lesser degrees of restenosis in the
two groups.
A principal limitation of the present study is that
we could not provide extrapolated 5-year outcomes
as was done in the ACAS, and we cannot comment
on 5-year stroke risk reduction in men and women.
Despite the fact that the experience reported here
dates back to January 1990, the volume of CEA pro-
cedures at our institution and nationwide12 has
markedly increased over the past 3 to 4 years. In fact,
most of the patients in the present study had CEA
performed less than 4 years ago. Therefore, mean
duration of follow-up is just over 2 years.
Additionally, one third of the patients in the study
were lost to follow-up, which precludes meaningful
conclusions on stroke risk reduction. These same
limitations should be applied in our results regarding
rates of recurrent carotid stenosis.
CONCLUSION
We have shown that female gender is not a risk
factor for perioperative stroke, death, or cardiac
morbidity afer CEA. We continue to believe that the
outcome of CEA is strongly influenced by surgical
excellence, which includes meticulous technique,
skilled intraoperative judgment, optimal postopera-
tive care, and appropriate patient selection. Men and
women should expect the same early postoperative
result from CEA.
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DISCUSSION
Dr Whittemore (Boston, Mass). I certainly enjoyed
your paper, and I am not surprised by your findings. I rise
to make just one comment, which is predicated on your
observations regarding the ACASS study. As you know,
the operative arm was required to undergo preoperative
cerebral angiography, and there were perioperative strokes
related to those arteriograms. I believe that two of the
three occurred in women, an observation that may intro-
duce some artifact into the conclusion that women derive
less benefit from endarterectomy than men. Do you use
preoperative angiography, or do you now operate based
on duplex or MRI alone, as most of us do now?
Dr Akbari (Boston, Mass). The incidence of arteriogra-
phy has dropped dramatically over this 8-year period. In
1990, for example, just over 90% of patients, almost 100%
of patients, underwent arteriography, whereas last year,
less than 4% underwent arteriography.
Dr Menzoian (Boston, Mass). That was a very nicely
presented paper. For years we were told that the recurrent
carotid stenosis was highest in women and highest in
women smokers, but your data clearly disproved that. In
fact, a recent paper in which they followed up all the
patients randomized in the ACASS trial also showed that
gender no longer made a difference in recurrent stenosis,
but the one thing that they did clearly point out was that
the only predictor of recurrent stenosis was whether you
patched or did not patch. I noticed that you selectively
patched based on size. Was there a correlation between
patching and no patching and recurrent carotid stenosis in
either gender, and how do you assess size?
Dr Akbari. First, is there a difference between patching
and no patching with respect to recurrent stenosis? Well,
our numbers are too small. Our definition of recurrent
stenosis was that requiring reoperation. As you well know,
multiple authors have looked at this, and multiple authors
have come up with differing conclusions.
What do we use for size? There is a trend at our insti-
tution now toward patching more routinely, probably
because technically, it is a little bit more forgiving than pri-
mary closure. What do we use for size? Well, it is difficult
for me to give you a number. If the artery certainly looks
small, if it is even difficult to get, for instance, a #10
French shunt, then we certainly are more prone to patch
that artery.
Dr Cronenwatt (Lebanon, NH). Cameron, these
results are really spectacular, and I think we would all like
to believe them. I am struggling to reconcile your results
with not just the ACASS, but several of the randomized
trials that have all tended to at least show a trend toward
less favorable outcome in women. I guess another way to
interpret your results could be that you might have
employed different selection criteria than were in the ran-
domized trials. For example, influenced by the random-
ized trials at least at our institution, we have, I think, been
somewhat more conservative about recommending
carotid surgery for women, particularly asymptomatic
patients where we might require a slightly more severe
stenosis before we recommend that treatment. So I won-
der if you have any reflections about your selection crite-
ria in men versus women during this period of time, and
do you think that there were any sort of induced changes
based on the studies that might have influenced your
results?
Dr Akbari. First, insofar as the original natural history
studies, which were done looking at the risk of stroke with
an asymptomatic stenosis, 80% appeared to be the cutoff
at which the risk of stroke increased. I think in the outset
of this study back in the early 1990s, an 80% cutoff was
used in men and women. With the publication of ACASS
and its conclusion regarding 60% stenosis, some of us have
gone to treating a 70% stenosis, but still there is no differ-
ence between men and women insofar as who we pick for
asymptomatic lesions.
Dr Darling (Albany, NY). That was a superb presenta-
tion, Cam, and our biases agree with your statistics. In our
experience there was no difference in outcome in either
men or women who had the carotid endarterectomy. The
question I have for you though is, if you looked at the
asymptomatic men and asymptomatic women, were the
results similar as far as stroke and mortality?
Dr Akbari. Postoperative stroke and mortality were
similar between men and women; however, we did not
specifically compare the asymptomatic group, mostly
because the numbers would be too small to draw accurate
statistical conclusions.
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